Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trialDaniel Catovsky, Peter Hillmen, Rachel Wade et al.|The Lancet|2007Cited by 679
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphomaDavid Martin‐García, Sı́lvia Beà, Alba Navarro et al.|Blood|2018Cited by 112
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Estella Matutes, Alessio Bruscaggin et al.|Blood|2021Cited by 96
Immunophenotyping in the diagnosis of acute leukaemias. General Haematology Task Force of BCSH.R. M. Rowan, James A. Bain, Julie England et al.|Journal of Clinical Pathology|1994Cited by 24
GENETIC AND PHENOTYPIC ATTRIBUTES OF SPLENIC MARGINAL ZONE LYMPHOMAFerdinando Bonfiglio, Michele Merli, Alessio Bruscaggin et al.|Hematological Oncology|2021Cited by 13